Citadel Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$706K Sell
257,700
-155,100
-38% -$491K ﹤0.01% 8473
2025
Q4
$1.53M Sell
412,800
-10,100
-2% -$32.6K ﹤0.01% 6464
2025
Q3
$1.12M Buy
422,900
+48,100
+13% +$93K ﹤0.01% 7294
2025
Q2
$369K Sell
374,800
-21,600
-5% -$21.6K ﹤0.01% 9334
2025
Q1
$571K Sell
396,400
-219,900
-36% -$405K ﹤0.01% 8194
2024
Q4
$1.36M Buy
616,300
+246,900
+67% +$576K ﹤0.01% 6428
2024
Q3
$610K Sell
369,400
-21,600
-6% -$43.6K ﹤0.01% 7837
2024
Q2
$868K Buy
391,000
+153,000
+64% +$360K ﹤0.01% 6878
2024
Q1
$638K Buy
238,000
+98,800
+71% +$240K ﹤0.01% 7848
2023
Q4
$416K Buy
139,200
+86,200
+163% +$112K ﹤0.01% 8486
2023
Q3
$51.9K Sell
53,000
-79,900
-60% -$116K ﹤0.01% 11719
2023
Q2
$185K Sell
132,900
-49,600
-27% -$69.3K ﹤0.01% 10014
2023
Q1
$290K Sell
182,500
-44,400
-20% -$229K ﹤0.01% 9446
2022
Q4
$1.41M Buy
226,900
+169,700
+297% +$1.21M ﹤0.01% 6161
2022
Q3
$383K Buy
57,200
+19,000
+50% +$130K ﹤0.01% 9042
2022
Q2
$243K Buy
38,200
+15,900
+71% +$90.2K ﹤0.01% 10279
2022
Q1
$103K Sell
22,300
-51,300
-70% -$220K ﹤0.01% 12254
2021
Q4
$368K Sell
73,600
-326,300
-82% -$2.61M ﹤0.01% 10442
2021
Q3
$4.82M Buy
399,900
+17,600
+5% +$256K ﹤0.01% 4369
2021
Q2
$8.09M Buy
382,300
+294,200
+334% +$7.09M ﹤0.01% 3454
2021
Q1
$2.47M Buy
88,100
+14,600
+20% +$431K ﹤0.01% 5906
2020
Q4
$1.91M Buy
73,500
+48,400
+193% +$1.45M ﹤0.01% 5436
2020
Q3
$933K Sell
25,100
-10,700
-30% -$424K ﹤0.01% 6157
2020
Q2
$1.84M Sell
35,800
-19,100
-35% -$799K ﹤0.01% 4734
2020
Q1
$1.73M Sell
54,900
-20,900
-28% -$1.1M ﹤0.01% 4388
2019
Q4
$4.52M Buy
75,800
+43,800
+137% +$1.97M ﹤0.01% 3208
2019
Q3
$1.17M Buy
32,000
+7,500
+31% +$297K ﹤0.01% 5312
2019
Q2
$1.14M Sell
24,500
-34,800
-59% -$1.63M ﹤0.01% 5483
2019
Q1
$2.38M Sell
59,300
-24,200
-29% -$1.09M ﹤0.01% 4168
2018
Q4
$3.84M Buy
83,500
+9,300
+13% +$448K ﹤0.01% 3173
2018
Q3
$3.29M Sell
74,200
-9,100
-11% -$418K ﹤0.01% 3584
2018
Q2
$3.27M Sell
83,300
-244,900
-75% -$12.4M ﹤0.01% 3349
2018
Q1
$23.7M Buy
328,200
+45,400
+16% +$3.33M 0.01% 992
2017
Q4
$18.6M Buy
282,800
+263,500
+1,365% +$14.2M 0.01% 1199
2017
Q3
$967K Buy
19,300
+800
+4% +$38.6K ﹤0.01% 4368
2017
Q2
$856K Sell
18,500
-29,200
-61% -$1.07M ﹤0.01% 4314
2017
Q1
$1.68M Buy
47,700
+37,700
+377% +$863K ﹤0.01% 3270
2016
Q4
$125K Buy
+10,000
New +$119K ﹤0.01% 6585
2016
Q2
Sell
-13,000
Closed -$220K 6949
2016
Q1
$220K Buy
13,000
+8,100
+165% +$130K ﹤0.01% 5520
2015
Q4
$109K Sell
4,900
-13,700
-74% -$346K ﹤0.01% 6586
2015
Q3
$439K Sell
18,600
-8,400
-31% -$527K ﹤0.01% 4985
2015
Q2
$2.21M Sell
27,000
-32,000
-54% -$3.13M ﹤0.01% 2957
2015
Q1
$5.46M Buy
+59,000
New +$3.81M 0.01% 1954

Other funds holding ESPR